Literature DB >> 2422920

Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumors of testis.

J Brenner, D Vugrin, W F Whitmore.   

Abstract

The effects of therapy on the sexual ability and fertility of sixty-seven patients with nonseminomatous germ cell tumors of the testis were analyzed. Ten of 38 patients had subfertile sperm counts before therapy. Normal ejaculation was preserved in only 7/61 patients who underwent retroperitoneal lymph node dissection. In five of these patients, sperm analysis was done after chemotherapy; all had complete azoospermia. An effort to restore ejaculation with imipramine yielded only minimal response in 4/9 patients who received this drug. No major long-term effects on the libido were observed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2422920     DOI: 10.1097/00000421-198504000-00014

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

1.  Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment? An experimental study in the mouse.

Authors:  M Nonomura; K Okada; S Hida; O Yoshida
Journal:  Urol Res       Date:  1991

2.  Long-term sequelae of treatment for testicular germ cell tumours.

Authors:  D Bissett; L Kunkeler; L Zwanenburg; J Paul; C Gray; I R Swan; D J Kerr; S B Kaye
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

3.  Long-term effects on sexual function and fertility after treatment of testicular cancer.

Authors:  J T Hartmann; C Albrecht; H J Schmoll; M A Kuczyk; C Kollmannsberger; C Bokemeyer
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.

Authors:  K D Jacobsen; S Ous; H Waehre; H Trasti; A E Stenwig; H H Lien; N Aass; S D Fosså
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.